Trial Profile

An observational, single-arm study of skeletal muscle metabolism in patients with rheumatoid arthritis receiving Tofacitinib

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tofacitinib (Primary)
Indications Rheumatoid arthritis
Focus Therapeutic Use
Acronyms RAMUS

Most Recent Events

15 Nov 2023 Primary endpoint (Change in muscle bulk measured by accelerated MRI of lower limbs) has been met according to Results presented at the ACR Convergence 2023.
15 Nov 2023 Results assessing effect of Tofacitinib treatment in rheumatoid arthritis associated with increased lower limb muscle volume presented at the ACR Convergence 2023
24 Mar 2023 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com